“…Tang et al, 2020;Xu and Qian, 2020 AChE, ACh Sevoflurane upregulates the expression of AChE, decreases the concentration of Ach, and downregulates the cholinergic anti-inflammatory pathway. Yin et al, 2019 GABA, GABAA receptors Sevoflurane decreases the concentration of GABA and potentiates GABAA receptors Cabrera et al, 2020;Zhang et al, 2020 Dopamine, dopamine receptors Sevoflurane accelerates dopamine turnover in the brain and increases the expression levels of the dopamine receptor genes Hayase et al, 2016;Taharabaru et al, 2018 Serotonin, SDM Sevoflurane sequesters acrolein and may promote the production of SDM that depletes local serotonin and enhances neuronal vulnerability Roberts et al, 2007;Miller et al, 2010;Brownrigg et al, 2011 NF-κB, nuclear factor-kappa B; IL, interleukin; PPAR-γ, peroxisome proliferator-activated receptor-γ; ROS, reactive oxygen species; NLRP3, Nod-like receptor protein 3; SIRT1, sirtuin 1; BDNF, brain-derived neurotrophic factor; AChE, acetylcholinesterase; Ach, acetylcholine; GABA, γ-aminobutyric acid; GABAA, GABA type A; SDM, serotonin-derived melanoid. The κ-opioid receptor agonist, oxycodone, an opioid widely used for postoperative pain, can downregulate the expression of inflammatory factors and attenuate POCD (Gan et al, 2020;Fan et al, 2021).…”